Literature DB >> 11014550

Treatment of spontaneous carotid-cavernous fistula in Ehlers-Danlos syndrome by transvenous occlusion with Guglielmi detachable coils. Case report and review of the literature.

A A Kanner1, S Maimon, Z H Rappaport.   

Abstract

The authors report on a young woman with Ehlers-Danlos syndrome (EDS) Type IV in whom a spontaneous direct carotid-cavernous fistula (CCF) was treated by transvenous occlusion with regular and fiber-coated Guglielmi detachable coils. To the authors' knowledge, this is the first time this approach has been used in a patient with EDS. The different treatment options are discussed, and the literature on endovascular treatment of direct CCFs in EDS is reviewed.

Entities:  

Mesh:

Year:  2000        PMID: 11014550     DOI: 10.3171/jns.2000.93.4.0689

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

1.  Clinical reasoning: a 21-year-old woman with right eye swelling and bruising.

Authors:  I M Ruff; D Strozyk; C Rahman; V Szeder; J Pile-Spellman; R S Marshall
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

Review 2.  More than one dilemma.

Authors:  Robert D Henderson; David G Walker; Ken Mitchell; Stephan J Read
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 3.  Ehlers-Danlos syndrome type IV and recurrent carotid-cavernous fistula: review of the literature, endovascular approach, technique and difficulties.

Authors:  H A Desal; F Toulgoat; S Raoul; B Guillon; S Bommard; E Naudou-Giron; E Auffray-Calvier; A de Kersaint-Gilly
Journal:  Neuroradiology       Date:  2005-04-06       Impact factor: 2.804

4.  A comparison of different transarterial embolization techniques for direct carotid cavernous fistulas: a single center experience in 32 patients.

Authors:  Xiaojian Lu; Mohammed Hussain; Lanchun Ni; Qinfeng Huang; Fei Zhou; Zhikai Gu; Jian Chen; Yuchuan Ding; Feng Xu
Journal:  J Vasc Interv Neurol       Date:  2014-12

5.  Treatment of a direct carotid-cavernous fistula in a patient with type IV Ehlers-Danlos syndrome: a novel approach.

Authors:  J K Hollands; T Santarius; P J Kirkpatrick; J N Higgins
Journal:  Neuroradiology       Date:  2006-05-06       Impact factor: 2.804

6.  A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.

Authors:  Sherene Shalhub; Peter H Byers; Kelli L Hicks; Kristofer Charlton-Ouw; Devin Zarkowsky; Dawn M Coleman; Frank M Davis; Ellen S Regalado; Giovanni De Caridi; K Nicole Weaver; Erin M Miller; Marc L Schermerhorn; Katie Shean; Gustavo Oderich; Mauricio Ribeiro; Cole Nishikawa; Christian-Alexander Behrendt; E Sebastian Debus; Yskert von Kodolitsch; Richard J Powell; Melanie Pepin; Dianna M Milewicz; Peter F Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-05-21       Impact factor: 4.268

7.  Endovascular treatment of direct carotid cavernous fistulae: a pictorial review.

Authors:  Arun K Gupta; Sukalyan Purkayastha; T Krishnamoorthy; Narendra K Bodhey; T R Kapilamoorthy; C Kesavadas; Bejoy Thomas
Journal:  Neuroradiology       Date:  2006-09-13       Impact factor: 2.804

8.  Endovascular GDC Treatment of an Idiopathic Carotid-Cavernous Fistula Caused by Aneurysmal Rupture of the Intra-Cavernous Carotid Artery. Case Report.

Authors:  Y Tatewaki; S Nishimura; M Ezura; A Nishino; K Sasaki; A Utsunomiya; S Suzuki; H Uenohara; Y Sakurai
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

9.  Carotid-cavernous fistula in ehlers-danlos syndrome by pure transvenous approach.

Authors:  O Van Overmeire; K De Keukeleire; P Van Langenhove; L Defreyne
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

10.  Endovascular treatment strategy for direct carotid-cavernous fistulas resulting from rupture of intracavernous carotid aneurysms.

Authors:  Nozomu Kobayashi; Shigeru Miyachi; Makoto Negoro; Osamu Suzuki; Koji Hattori; Takao Kojima; Jun Yoshida
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.